SJ Sharkis - Concepedia

Concepedia

Author

SJ Sharkis

Johns Hopkins University

Also Known As

S J Sharkis, SJ Sharkis

43

Publications

2.4K

Citations

20

H-Index

20

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Johns Hopkins Bayview Medical Center Johns Hopkins Hospital Naval Medical Research Command

SS

About

SJ Sharkis is an author at Johns Hopkins University specializing in cell biology, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	22
2	Medicine	2	2	22
3	Cell Biology	2	2	22
4	Cellular Therapies	1	1	12
5	Immunology	1	1	12

SJ Sharkis

×

25

Publications

2.4K

Citations

20

H-Index

	Year	Citations
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia A Bedi, BA Zehnbauer, SJ Sharkis, Blood	1994	496
Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells DS Krause, Toshiharu Ito, MJ Fackler, Blood	1994	271
Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide SJ Sharkis, GW Santos, M Colvin Blood	1980	217
Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells DS Krause, T Ito, MJ Fackler, Blood	1994	215
Two phases of engraftment established by serial bone marrow transplantation in mice RJ Jones, P Celano, SJ Sharkis, Blood	1989	177
Two phases of engraftment established by serial bone marrow transplantation in mice R. G. Wyn Jones, P Celano, SJ Sharkis, Blood	1989	140
BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia A Bedi, BA Zehnbauer, MI Collector, Blood	1993	123
Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies SB Baylin, ER Fearon, Bert Vogelstein, Blood	1987	114
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro RJ Jones, SJ Sharkis, CB Miller, Blood	1990	95
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro RJ Jones, SJ Sharkis, CB Miller, Blood	1990	72

Page 1